Gladstone Institutional Advisory LLC Teva Pharmaceutical Industries LTD Transaction History

Gladstone Institutional Advisory LLC

$2.5 Billion
Q3 2025

A detailed history of Gladstone Institutional Advisory LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Gladstone Institutional Advisory LLC holds 17,572 shares of TEVA stock, worth $446,504. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,572

Previous 14,872 18.15%

Holding current value

$446,504

Previous $228,000 55.26%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 22, 2025	BUY	$15.38 - $20.2 $41,526 - $54,540	2,700 Added 18.15%	17,572 $354,000
Q1 2025 May 15, 2025	SELL	$14.67 - $22.01 $2.04 Million - $3.07 Million	-139,377 Reduced 90.36%	14,872 $228,000
Q4 2024 Jan 29, 2025	BUY	$16.43 - $22.77 $169,393 - $234,758	10,310 Added 7.16%	154,249 $3.4 Million
Q3 2024 Oct 28, 2024	BUY	$15.81 - $18.96 $2.04 Million - $2.44 Million	128,748 Added 847.53%	143,939 $2.59 Million
Q2 2024 Aug 02, 2024	SELL	$12.78 - $17.4 $1,917 - $2,610	-150 Reduced 0.98%	15,191 $246,000

Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $12,590 - $17,027	1,180 Added 8.33%	15,341 $216,000
Q4 2023 Feb 09, 2024	BUY	$8.12 - $10.63 $4,669 - $6,112	575 Added 4.23%	14,161 $147,000
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $8,268 - $11,244	-989 Reduced 6.79%	13,586 $120,000
Q2 2022 Jan 27, 2023	SELL	$7.38 - $10.4 $944 - $1,331	-128 Reduced 0.87%	14,575 $110,000
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $944 - $1,331	-128 Reduced 0.87%	14,575 $110,000
Q1 2022 Jan 27, 2023	BUY	$7.33 - $9.39 $938 - $1,201	128 Added 0.88%	14,703 $138,000
Q1 2022 May 04, 2022	BUY	$7.33 - $9.39 $107,772 - $138,061	14,703 New	14,703 $138,000

Others Institutions Holding TEVA

# of Institutions

668

Shares Held

623M

Call Options Held

30.8M

Put Options Held

18.5M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $28.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gladstone Institutional Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gladstone Institutional Advisory LLC with notifications on news.

Account

Gladstone Institutional Advisory LLC Teva Pharmaceutical Industries LTD Transaction History